Resources Repository
-
ArticlePublication 2019Country Contextualization of Cost-Effectiveness Studies
This article, published in BMJ Global Health, provides experiences of country contextualization of WHO-CHOICE methods …
This article, published in BMJ Global Health, provides experiences of country contextualization of WHO-CHOICE methods and models to a country level. Results from three contextualized cost-effectiveness analyses (CEAs) are presented, and the authors discuss how this evidence can inform priority setting in Ethiopia. This method of contextualized CEAs requires inclusion of national analysts and use of country-specific inputs for either costs, epidemiology, demography, baseline coverage or effects. Rank ordering of interventions by incremental cost-effectiveness ratios…
Health/Medicine | Policy/Regulation | Health Systems | Cost-Effectiveness Analysis | Clinical Care | Sub-Saharan Africa -
DataWeb Portal 2024Global Health Observatory Data Portal
This data portal is the World Health Organization's (WHO) main health statistics repository. The Global …
This data portal is the World Health Organization's (WHO) main health statistics repository. The Global Health Observatory (GHO) provides access to more than 1,000 indicators on priority health topics including mortality and burden of diseases, the Sustainable Development Goals, noncommunicable diseases and risk factors, epidemic-prone diseases, health systems, environmental health, violence and injuries, and health equity. In addition, the GHO provides access to WHO's analytical reports on the current status and trends of priority health…
Health/Medicine | Health Systems | Mental Health | Evidence Synthesis | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Chronic Disease/Risk | Injuries/Accidents | Global Governance | Global -
Resource PackPublication, Teaching Resource 2019Resource Pack: BCA in Low- and Middle-Income Countries
This resource pack, curated by the Center for Health Decision Science, includes methods papers, case …
This resource pack, curated by the Center for Health Decision Science, includes methods papers, case studies, and reference case guidance for conducting benefit-cost analyses in low- and middle-income countries. These resources will aid advanced students and experienced practitioners in preparing these analyses. Investing in global health and development requires making difficult choices about what initiatives to fund and what level of resources to devote to each initiative. Although benefit-cost analysis is a well-established and widely-used…
Health/Medicine | Policy/Regulation | Social Determinants | Preferences/Values | Priority Setting/Ethics | Decision Analysis | Benefit-Cost Analysis | Economics/Finance | Global | Graduate | Doctoral | Professional | Critical Thinking/Analysis -
Resource PackPublication, Teaching Resource 2024Resource Pack: Introduction to Benefit-Cost Analysis
This resource pack, curated by the Center for Health Decision Science, introduces the theory and …
This resource pack, curated by the Center for Health Decision Science, introduces the theory and practice of benefit-cost analysis. It is targeted towards advanced students as well as practitioners and those interested in teaching benefit-cost analysis. Benefit-cost analysis (also referred to as cost-benefit analysis) is a well-established and widely-used form of economic evaluation. It is designed to inform policy and other decisions by providing evidence on the consequences of alternative interventions. In benefit-cost analysis, all…
Health/Medicine | Policy/Regulation | Social Determinants | Preferences/Values | Priority Setting/Ethics | Decision Analysis | Benefit-Cost Analysis | Climate/Environment | Economics/Finance | Government/Law | Global | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis -
OrganizationWeb Portal 2024Society for Benefit-Cost Analysis
The Society for Benefit-Cost Analysis (SBCA), founded in 2007, works to improve the theory and …
The Society for Benefit-Cost Analysis (SBCA), founded in 2007, works to improve the theory and practice of benefit-cost analysis and support evidence-based policy decisions. It addresses policy areas including public health, transportation, criminal justice, education, energy, environmental quality, homeland security, and poverty. Members include scholars and practitioners from around the world, who work in government, academia, nonprofits and private industry. Its members represent numerous disciplines such as economics, law, engineering, public policy, decision science, and…
Health/Medicine | Policy/Regulation | Social Determinants | Preferences/Values | Priority Setting/Ethics | Costing Methods | Benefit-Cost Analysis | Environmental Health | Business/Industry | Climate/Environment | Economics/Finance | Energy/Engineering | Education/Labor | Food/Agriculture | Government/Law | Military/Defense | Science/Technology | Global | Critical Thinking/Analysis -
Teaching PackWeb Portal, Teaching Resource 2018Teaching Pack: A Methods Sampler
This teaching pack features a collection of videos by Professor David Cutler, introducing basic concepts in …
This teaching pack features a collection of videos by Professor David Cutler, introducing basic concepts in epidemiology, economics and statistics, to support his undergraduate course, "EMR20: Why is There No Cure for Health Care?" Concept sketches, prototypes, and videos were completed and produced during Cutler's collaborative residency at the Global Health Education and Learning Incubator (GHELI).Videos include: EMR20: What is an Epidemic? (~10 min) EMR20: Dynamics of an Epidemic (~13 min) EMR20: The Economics of Pharmaceuticals, Part 1 (~20 min)…
Health/Medicine | Policy/Regulation | Social Determinants | Infectious Diseases | Business/Industry | Economics/Finance | Global | North America | High School | College | Graduate | Critical Thinking/Analysis | Quantitative Literacy -
ReportPublication 2017DCP3: Cardiovascular, Respiratory, and Related Disorders
This report from the World Bank is the fifth volume of the Disease Control Priorities, …
This report from the World Bank is the fifth volume of the Disease Control Priorities, Third Edition (DCP3) series. It addresses the disease burden of cardiovascular, respiratory, and related disorders (CVRDs), which account for more than half of global adult deaths, mostly in low- and middle-income countries. While CVRDs are mostly preventable or can be treated to reduce morbidity, such interventions are costly and require greater capacity to detect and treat early. When combined with…
Health/Medicine | Health Systems | Social Determinants | Costing Methods | Health Outcomes | Evidence Synthesis | Cost-Effectiveness Analysis | Chronic Disease/Risk | Global Governance | Climate/Environment | Global -
ReportPublication 2016DCP3: Mental, Neurological, and Substance Use Disorders
This report from the World Bank is the fourth volume of the Disease Control Priorities, …
This report from the World Bank is the fourth volume of the Disease Control Priorities, Third Edition (DCP3) series. It discusses the prevalence of mental, neurological, and substance use disorders, as well as the associated disability and premature mortality that can accompany them. Despite the high social and economic burden of these diseases on individuals, families, and communities, these disorders have been systematically neglected, especially in low- and middle-income countries, and there has been limited…
Health/Medicine | Health Systems | Mental Health | Costing Methods | Health Outcomes | Evidence Synthesis | Cost-Effectiveness Analysis | Global Governance | Economics/Finance | Global -
ReportPublication 2010Priorities for the National Vaccine Plan
The authors examine the complexities of the vaccine enterprise, a fundamental component of preventive medicine …
The authors examine the complexities of the vaccine enterprise, a fundamental component of preventive medicine and public health, from research and development of new vaccines to financing and reimbursement of immunization services. The current climate, socially, economically and politically, presents challenges and opportunities to the U.S. to strengthen the existing systems of developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. The authors present recommendations for priority actions intended to…
Health/Medicine | Policy/Regulation | Health Systems | Evidence Synthesis | Technology Assessment | Infectious Diseases | Chronic Disease/Risk | Economics/Finance | Science/Technology | North America